Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.
2.

Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.

Pedersen SJ, Sørensen IJ, Hermann KG, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Johansen JS, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Skjødt T, Hansen A, Ostergaard M.

Ann Rheum Dis. 2010 Jun;69(6):1065-71. doi: 10.1136/ard.2009.111187. Epub 2009 Sep 9.

PMID:
19740906
[PubMed - indexed for MEDLINE]
3.

Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.

Salaffi F, Ciapetti A, Carotti M, Gasparini S, Citera G, Gutierrez M.

Health Qual Life Outcomes. 2014 Aug 22;12(1):129. doi: 10.1186/s12955-014-0129-9.

PMID:
25146299
[PubMed - in process]
Free Article
4.

Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial.

Song IH, Weiß A, Hermann KG, Haibel H, Althoff CE, Poddubnyy D, Listing J, Lange E, Freundlich B, Rudwaleit M, Sieper J.

Ann Rheum Dis. 2013 Jun;72(6):823-5. doi: 10.1136/annrheumdis-2012-202389. Epub 2012 Nov 21.

PMID:
23172749
[PubMed - indexed for MEDLINE]
5.

[The clinical analysis for the whole-spine magnetic resonance imaging of axial spondyloarthritis].

Luo G, Zhao Z, Zhu J, Zhang J, Huang F.

Zhonghua Nei Ke Za Zhi. 2014 Jun;53(6):464-8. Chinese.

PMID:
25146515
[PubMed - in process]
6.

Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy.

Jauregui E, Conner-Spady B, Russell AS, Maksymowych WP.

J Rheumatol. 2004 Dec;31(12):2422-8.

PMID:
15570645
[PubMed - indexed for MEDLINE]
7.

Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).

Sieper J, van der Heijde D, Dougados M, Mease PJ, Maksymowych WP, Brown MA, Arora V, Pangan AL.

Ann Rheum Dis. 2013 Jun;72(6):815-22. doi: 10.1136/annrheumdis-2012-201766. Epub 2012 Jul 7.

PMID:
22772328
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Evaluation of spondylarthritis activity by patients and physicians: ASDAS, BASDAI, PASS, and flares in 200 patients.

Godfrin-Valnet M, Prati C, Puyraveau M, Toussirot E, Letho-Gyselink H, Wendling D.

Joint Bone Spine. 2013 Jul;80(4):393-8. doi: 10.1016/j.jbspin.2013.01.003. Epub 2013 Mar 1.

PMID:
23453478
[PubMed - indexed for MEDLINE]
9.

ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.

Pedersen SJ, Sørensen IJ, Garnero P, Johansen JS, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Skjødt T, Lambert R, Hansen A, Østergaard M.

Ann Rheum Dis. 2011 Aug;70(8):1375-81. doi: 10.1136/ard.2010.138883. Epub 2011 May 8.

PMID:
21551511
[PubMed - indexed for MEDLINE]
10.

Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.

Fernández-Espartero C, de Miguel E, Loza E, Tomero E, Gobbo M, Descalzo MA, Collantes-Estévez E, Mulero J, Muñoz-Fernández S, Zarco P, Carmona L; ESPERANZA Study Group.

Ann Rheum Dis. 2014 Jul;73(7):1350-5. doi: 10.1136/annrheumdis-2012-202976. Epub 2013 May 24.

PMID:
23709245
[PubMed - indexed for MEDLINE]
11.

Consistently Good Clinical Response in Patients with Early Axial Spondyloarthritis After 3 Years of Continuous Treatment with Etanercept: Longterm Data of the ESTHER Trial.

Song IH, Hermann KG, Haibel H, Althoff CE, Poddubnyy D, Listing J, Weiß A, Buß B, Freundlich B, Lange E, Alten R, Rudwaleit M, Sieper J.

J Rheumatol. 2014 Jul 15. pii: jrheum.140056. [Epub ahead of print]

PMID:
25028375
[PubMed - as supplied by publisher]
12.

MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor.

Machado P, Landewé RB, Braun J, Baraliakos X, Hermann KG, Hsu B, Baker D, van der Heijde D.

Ann Rheum Dis. 2012 Dec;71(12):2002-5. doi: 10.1136/annrheumdis-2012-201999. Epub 2012 Aug 21.

PMID:
22915615
[PubMed - indexed for MEDLINE]
13.

Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial.

Dougados M, van der Heijde D, Sieper J, Braun J, Maksymowych WP, Citera G, Miceli-Richard C, Wei JC, Pedersen R, Bonin R, Rahman MU, Logeart I, Wajdula J, Koenig AS, Vlahos B, Alvarez D, Bukowski JF.

Arthritis Rheumatol. 2014 Aug;66(8):2091-102. doi: 10.1002/art.38721.

PMID:
24891317
[PubMed - in process]
14.

Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis.

Hu Z, Xu M, Li Q, Lin Z, Liao Z, Cao S, Wei Q, Zhang YL, Li T, Jin O, Huang J, Pan Y, Wu Y, Deng X, Gu J.

Int J Rheum Dis. 2012 Aug;15(4):358-65. doi: 10.1111/j.1756-185X.2012.01734.x. Epub 2012 May 23. Erratum in: Int J Rheum Dis. 2012 Dec;15(6):564.

PMID:
22898215
[PubMed - indexed for MEDLINE]
15.

Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis.

van der Heijde D, Sieper J, Maksymowych WP, Brown MA, Lambert RG, Rathmann SS, Pangan AL.

Arthritis Rheumatol. 2014 Mar;66(3):667-73. doi: 10.1002/art.38283.

PMID:
24574227
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.

Ciurea A, Scherer A, Exer P, Bernhard J, Dudler J, Beyeler B, Kissling R, Stekhoven D, Rufibach K, Tamborrini G, Weiss B, Müller R, Nissen MJ, Michel BA, van der Heijde D, Dougados M, Boonen A, Weber U; Rheumatologists of the Swiss Clinical Quality Management Program for Axial Spondyloarthritis.

Arthritis Rheum. 2013 Dec;65(12):3096-106. doi: 10.1002/art.38140.

PMID:
23983141
[PubMed - indexed for MEDLINE]
17.

Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?

Kiltz U, Baraliakos X, Karakostas P, Igelmann M, Kalthoff L, Klink C, Krause D, Schmitz-Bortz E, Flörecke M, Bollow M, Braun J.

Arthritis Care Res (Hoboken). 2012 Sep;64(9):1415-22. doi: 10.1002/acr.21688.

PMID:
22505331
[PubMed - indexed for MEDLINE]
18.

Evaluation of the Iranian versions of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Patient Acceptable Symptom State (PASS) in patients with ankylosing spondylitis.

Bidad K, Fallahi S, Mahmoudi M, Jamshidi A, Farhadi E, Meysamie A, Nicknam MH.

Rheumatol Int. 2012 Nov;32(11):3613-8. doi: 10.1007/s00296-011-2186-2. Epub 2011 Nov 20.

PMID:
22101612
[PubMed - indexed for MEDLINE]
19.

Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity.

Salaffi F, De Angelis R, Carotti M, Gutierrez M, Sarzi-Puttini P, Atzeni F.

Rheumatol Int. 2014 Aug;34(8):1103-10. doi: 10.1007/s00296-014-2955-9. Epub 2014 Feb 8.

PMID:
24509896
[PubMed - in process]
20.

MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis.

Rudwaleit M, Schwarzlose S, Hilgert ES, Listing J, Braun J, Sieper J.

Ann Rheum Dis. 2008 Sep;67(9):1276-81. Epub 2007 Nov 15.

PMID:
18006539
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk